Wealthspire Advisors (Maryland)’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-72
Closed -$2K 538
2019
Q1
$2K Hold
72
﹤0.01% 2116
2018
Q4
$1K Buy
+72
New +$1.49K ﹤0.01% 2214
2018
Q1
Sell
-6
Closed 2488
2017
Q4
$0 Hold
6
﹤0.01% 2429
2017
Q3
$0 Buy
+6
New +$101 ﹤0.01% 2241

Other funds holding ANGO

Wealthspire Advisors (Maryland)'s ANGO Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of AngioDynamics (ANGO) in Q2 2019, closing a stake of 72 shares — an estimated $2K sold.

Wealthspire Advisors (Maryland) first reported a position in ANGO in Q3 2017 and held it in 4 quarters. The position peaked at $2K in Q1 2019. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining AngioDynamics position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 72 AngioDynamics shares in Q2 2019, an estimated $2K.
  • Wealthspire Advisors (Maryland) first reported a position in AngioDynamics in Q3 2017 and held it in 4 quarters.
  • Wealthspire Advisors (Maryland)'s AngioDynamics position peaked at $2K in Q1 2019.
  • 167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.